Antineutrophil cytoplasmic antibodies in patients treated with methimazole: a prospective Brazilian study
- 1 September 2019
- journal article
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 85 (5) , 636-641
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of ThyrotoxicosisThyroid®, 2016
- Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole TreatmentThyroid®, 2015
- Antineutrophil Cytoplasmic Antibody–Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy: How Significant Is the Clinical Problem?Thyroid®, 2015
- Anticuerpos contra el citoplasma del neutrófilo: positividad y correlación clínicaReumatología Clínica, 2015
- Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatmentInternational Journal Of Clinical Practice, 2010
- Diagnostic Role and Clinical Association of ASCA and ANCA in Brazilian Patients with Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2009
- Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long‐term followup studyArthritis Care & Research, 2005
- Propylthiouracil and carbimazole associated‐antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves’ diseaseClinical Endocrinology, 2004
- The Prevalence and Target Antigens of Antithyroid Drugs Induced Antineutrophil Cytoplasmic Antibodies (ANCA) in Chinese Patients with HyperthyroidismEndocrine Research, 2004
- Treatment with Propylthiouracil is Associated with Appearance of Antineutrophil Cytoplasmic Antibodies in Some Patients with Graves' DiseaseThyroid®, 2000